Literature DB >> 12601807

Identification of cellular changes associated with increased production of human growth hormone in a recombinant Chinese hamster ovary cell line.

Derek D Van Dyk1, David R Misztal, Marc R Wilkins, James A Mackintosh, Anne Poljak, Jodie C Varnai, Erdahl Teber, Bradley J Walsh, Peter P Gray.   

Abstract

A proteomics approach was used to identify the proteins potentially implicated in the cellular response concomitant with elevated production levels of human growth hormone in a recombinant Chinese hamster ovary (CHO) cell line following exposure to 0.5 mM butyrate and 80 microM zinc sulphate in the production media. This involved incorporation of two-dimensional (2-D) gel electrophoresis and protein identification by a combination of N-terminal sequencing, matrix-assisted laser desorption/ionisation-time of flight mass spectrometry, amino acid analysis and cross species database matching. From these identifications a CHO 2-D reference map and annotated database have been established. Metabolic labelling and subsequent autoradiography showed the induction of a number of cellular proteins in response to the media additives butyrate and zinc sulphate. These were identified as GRP75, enolase and thioredoxin. The chaperone proteins GRP78, HSP90, GRP94 and HSP70 were not up-regulated under these conditions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12601807     DOI: 10.1002/pmic.200390023

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  10 in total

1.  Proteomic profiling of recombinant cells from large-scale mammalian cell culture processes.

Authors:  Paula Meleady
Journal:  Cytotechnology       Date:  2007-02-24       Impact factor: 2.058

2.  Using cell engineering and omic tools for the improvement of cell culture processes.

Authors:  Darrin Kuystermans; Britta Krampe; Halina Swiderek; Mohamed Al-Rubeai
Journal:  Cytotechnology       Date:  2007-02-24       Impact factor: 2.058

3.  Toward genomic cell culture engineering.

Authors:  Katie F Wlaschin; Gargi Seth; Wei-Shou Hu
Journal:  Cytotechnology       Date:  2006-07-25       Impact factor: 2.058

4.  Comprehensive tracking of host cell proteins during monoclonal antibody purifications using mass spectrometry.

Authors:  Qingchun Zhang; Andrew M Goetze; Huanchun Cui; Jenna Wylie; Steve Trimble; Art Hewig; Gregory C Flynn
Journal:  MAbs       Date:  2014-02-11       Impact factor: 5.857

5.  Glycoengineering of Mammalian Expression Systems on a Cellular Level.

Authors:  Kelley M Heffner; Qiong Wang; Deniz Baycin Hizal; Özge Can; Michael J Betenbaugh
Journal:  Adv Biochem Eng Biotechnol       Date:  2021       Impact factor: 2.635

Review 6.  Current state and recent advances in biopharmaceutical production in Escherichia coli, yeasts and mammalian cells.

Authors:  Aleš Berlec; Borut Strukelj
Journal:  J Ind Microbiol Biotechnol       Date:  2013-02-06       Impact factor: 3.346

7.  A proteomic study of cMyc improvement of CHO culture.

Authors:  Darrin Kuystermans; Michael J Dunn; Mohamed Al-Rubeai
Journal:  BMC Biotechnol       Date:  2010-03-22       Impact factor: 2.563

8.  Proteomic differences in recombinant CHO cells producing two similar antibody fragments.

Authors:  Wolfgang Sommeregger; Patrick Mayrhofer; Willibald Steinfellner; David Reinhart; Michael Henry; Martin Clynes; Paula Meleady; Renate Kunert
Journal:  Biotechnol Bioeng       Date:  2016-03-16       Impact factor: 4.530

9.  GADD153 expression does not necessarily correlate with changes in culture behavior of hybridoma cells.

Authors:  Matthew Mallory; Kevin Chartrand; Eric R Gauthier
Journal:  BMC Biotechnol       Date:  2007-12-10       Impact factor: 2.563

Review 10.  CHO microRNA engineering is growing up: recent successes and future challenges.

Authors:  Vaibhav Jadhav; Matthias Hackl; Aliaksandr Druz; Smriti Shridhar; Cheng-Yu Chung; Kelley M Heffner; David P Kreil; Mike Betenbaugh; Joseph Shiloach; Niall Barron; Johannes Grillari; Nicole Borth
Journal:  Biotechnol Adv       Date:  2013-08-02       Impact factor: 14.227

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.